Company intelligence / Profile preview

Sonmol

Shanghai, Shanghai Municipality, Chinasonmolmed.com ↗

Ownership: Private
Development stage: Commercial

Overview

Sonmol has developed and commercialized a suite of connected respiratory drug delivery devices combined with a digital health platform for remote monitoring, patient engagement, and chronic respiratory disease management. The company’s solutions are used by over 2 million customers in more than 20 countries. Clinical results per se are not reported as the focus is on device/software rather than pharmaceuticals.

Therapeutic areas: Pulmonology
Modalities: DeviceDigital health platformArtificial intelligence disease model
Industry: Therapeutic Medical Devices

Partnerships

AptarGroup/Aptar Pharma (strategic partnership for connected device development, manufacturing, commercialization)

Beyond the preview

Go deeper on Sonmol.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sonmol.

Explore the full profile